These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35918411)

  • 1. Discovery and identification of a novel small molecule BCL-2 inhibitor that binds to the BH4 domain.
    Zhou JY; Yang RR; Chang J; Song J; Fan ZS; Zhang YH; Lu CH; Jiang HL; Zheng MY; Zhang SL
    Acta Pharmacol Sin; 2023 Feb; 44(2):475-485. PubMed ID: 35918411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth.
    Lin Y; Zhao Y; Chen M; Li Z; Liu Q; Chen J; Ding Y; Ding C; Ding Y; Qi C; Zheng L; Li J; Zhang R; Zhou J; Wang L; Zhang QQ
    BMC Cancer; 2023 May; 23(1):479. PubMed ID: 37237269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH4 domain of Bcl-2 as a novel target for cancer therapy.
    Liu Z; Wild C; Ding Y; Ye N; Chen H; Wold EA; Zhou J
    Drug Discov Today; 2016 Jun; 21(6):989-96. PubMed ID: 26631752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-canonical roles of Bcl-2 and Bcl-xL proteins: relevance of BH4 domain.
    Gabellini C; Trisciuoglio D; Del Bufalo D
    Carcinogenesis; 2017 Jun; 38(6):579-587. PubMed ID: 28203756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer cell death strategies by targeting Bcl-2's BH4 domain.
    de Ridder I; Kerkhofs M; Veettil SP; Dehaen W; Bultynck G
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(5):118983. PubMed ID: 33549704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.
    Lavik AR; Zhong F; Chang MJ; Greenberg E; Choudhary Y; Smith MR; McColl KS; Pink J; Reu FJ; Matsuyama S; Distelhorst CW
    Oncotarget; 2015 Sep; 6(29):27388-402. PubMed ID: 26317541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double point mutation at residues Ile14 and Val15 of Bcl-2 uncovers a role for the BH4 domain in both protein stability and function.
    Monaco G; La Rovere R; Karamanou S; Welkenhuyzen K; Ivanova H; Vandermarliere E; Di Martile M; Del Bufalo D; De Smedt H; Parys JB; Economou A; Bultynck G
    FEBS J; 2018 Jan; 285(1):127-145. PubMed ID: 29131545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.
    Vervloessem T; Sasi BK; Xerxa E; Karamanou S; Kale J; La Rovere RM; Chakraborty S; Sneyers F; Vogler M; Economou A; Laurenti L; Andrews DW; Efremov DG; Bultynck G
    Cell Death Dis; 2020 Sep; 11(9):769. PubMed ID: 32943617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.
    Rong YP; Barr P; Yee VC; Distelhorst CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):971-8. PubMed ID: 19056433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.
    Trisciuoglio D; De Luca T; Desideri M; Passeri D; Gabellini C; Scarpino S; Liang C; Orlandi A; Del Bufalo D
    Neoplasia; 2013 Mar; 15(3):315-27. PubMed ID: 23479509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.
    Banta KL; Wang X; Das P; Winoto A
    J Biol Chem; 2018 Mar; 293(13):4724-4734. PubMed ID: 29414782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.
    Rong YP; Bultynck G; Aromolaran AS; Zhong F; Parys JB; De Smedt H; Mignery GA; Roderick HL; Bootman MD; Distelhorst CW
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14397-402. PubMed ID: 19706527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death.
    Shimizu S; Konishi A; Kodama T; Tsujimoto Y
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3100-5. PubMed ID: 10737788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.
    Gabellini C; De Luca T; Trisciuoglio D; Desideri M; Di Martile M; Passeri D; Candiloro A; Biffoni M; Rizzo MG; Orlandi A; Del Bufalo D
    Carcinogenesis; 2013 Nov; 34(11):2558-67. PubMed ID: 23836782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BH4 domain of Bcl-2 orthologues from different classes of vertebrates can act as an evolutionary conserved inhibitor of IP
    Ivanova H; Luyten T; Decrock E; Vervliet T; Leybaert L; Parys JB; Bultynck G
    Cell Calcium; 2017 Mar; 62():41-46. PubMed ID: 28179071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
    Park D; Anisuzzaman ASM; Magis AT; Chen G; Xie M; Zhang G; Behera M; Sica GL; Ramalingam SS; Owonikoko TK; Deng X
    Theranostics; 2021; 11(17):8500-8516. PubMed ID: 34373755
    [No Abstract]   [Full Text] [Related]  

  • 18. The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria.
    Monaco G; Decrock E; Arbel N; van Vliet AR; La Rovere RM; De Smedt H; Parys JB; Agostinis P; Leybaert L; Shoshan-Barmatz V; Bultynck G
    J Biol Chem; 2015 Apr; 290(14):9150-61. PubMed ID: 25681439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress.
    Cantara S; Donnini S; Giachetti A; Thorpe PE; Ziche M
    J Vasc Res; 2004; 41(2):202-7. PubMed ID: 15031604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2.
    Pohl SÖ; Agostino M; Dharmarajan A; Pervaiz S
    Antioxid Redox Signal; 2018 Nov; 29(13):1215-1236. PubMed ID: 29304561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.